Loading
Latest filing published 21 Apr 2025 for CHIMERIX INC, €452k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Thomas J. Riga, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Spectrum Pharmaceuticals Inc and Chimerix Inc. The record holds 11 filings, for trades running from 13 May 2021 to 21 April 2025.
No open-market purchase appears, only 7 sales worth €102k. Outside the open market, there are 2 share grants.
The latest filing, published on 21 April 2025, reports a transaction of €452k in Chimerix Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations